Related Experiment Video

Updated: Jun 3, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Patient volume, human resource levels, and attrition from HIV treatment programs in central Mozambique

Barrot H Lambdin1, Mark A Micek, Thomas D Koepsell

  • 1Pangaea Global AIDS Foundation, Oakland, CA, USA. blambdin@pgaf.org

Journal of Acquired Immune Deficiency Syndromes (1999)
|March 5, 2011
PubMed

Insights

High pharmacy staff burden in HIV clinics is linked to increased patient attrition. Addressing these human resource shortages is crucial for improving antiretroviral therapy (ART) program retention in Mozambique.

Area of Science:

  • Public Health
  • HIV/AIDS Research
  • Health Systems Strengthening

Background:

  • Human resource shortages are a major barrier to effective HIV services and antiretroviral therapy (ART) access.
  • Growing patient populations on ART require efficient service delivery.
  • This study investigates factors influencing attrition from HIV treatment programs in Mozambique.

Purpose of the Study:

  • To examine the relationship between human resource levels (clinical and pharmacy staff burden) and patient volume with attrition from HIV treatment programs.
  • To identify specific areas within the health system that impact patient retention in HIV care.

Main Methods:

  • Retrospective cohort study of 11,793 adult, ART-naive patients initiating ART between 2006 and 2008 in central Mozambique.
  • Cox proportional hazards models were used to assess attrition risk.
  • Adjusted for patient characteristics, patient volume, clinical staff burden, and pharmacy staff burden.

Main Results:

  • Higher pharmacy staff burden was significantly associated with increased risk of attrition (HR=1.39 for medium, HR=2.09 for high burden).
  • Higher patient volume showed a trend towards increased attrition risk, but was not statistically significant.
  • No statistically significant association was found between clinical staff burden and attrition risk.

Conclusions:

  • Increased pharmacy staff burden is a key factor contributing to higher attrition rates in HIV treatment programs.
  • Interventions targeting pharmacy staffing levels may improve patient retention in HIV care.
  • Addressing human resource challenges is vital for the success of ART programs.
Abstract

More Related Videos

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection08:14

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

Published on: October 6, 2015

Related Concept Videos

Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...